The prognostic value of estrogen receptor determinations in patients with primary breast cancer: An update

Philip Furmanski; Dwight E. Saunders; Samuel C. Brooks; Marvin A. Rich

doi:10.1002/1097-0142(19801215)46:12+<2794::AID-CNCR2820461410>3.0.CO;2-N

The prognostic value of estrogen receptor determinations in patients with primary breast cancer: An update

Philip Furmanski, Dwight E. Saunders, Samuel C. Brooks, Marvin A. Rich

Research output: Contribution to journal › Article › peer-review

58 Scopus citations

Abstract

Patients with estrogen receptor (E₂R)‐positive breast cancers experience a longer disease‐free interval and longer survival following primary surgery than do patients with E₂R‐negative tumors. The presence of E₂R is correlated with patient age at diagnosis and tumor grade but not with the presence of metastatic foci in axillary lymph nodes. The difference in the rates of recurrence between E₂R‐positive and negative tumors is greater in pre‐ and perimenopausal patients than in postmenopausal patients.

Original language	English (US)
Pages (from-to)	2794-2796
Number of pages	3
Journal	Cancer
Volume	46
Issue number	12 S
DOIs	https://doi.org/10.1002/1097-0142(19801215)46:12+<2794::AID-CNCR2820461410>3.0.CO;2-N
State	Published - Dec 15 1980
Externally published	Yes

All Science Journal Classification (ASJC) codes

Oncology
Cancer Research

Access to Document

10.1002/1097-0142(19801215)46:12+<2794::AID-CNCR2820461410>3.0.CO;2-N

Cite this

@article{6672472aa6af49a691d335b8afe840fb,

title = "The prognostic value of estrogen receptor determinations in patients with primary breast cancer: An update",

abstract = "Patients with estrogen receptor (E2R)‐positive breast cancers experience a longer disease‐free interval and longer survival following primary surgery than do patients with E2R‐negative tumors. The presence of E2R is correlated with patient age at diagnosis and tumor grade but not with the presence of metastatic foci in axillary lymph nodes. The difference in the rates of recurrence between E2R‐positive and negative tumors is greater in pre‐ and perimenopausal patients than in postmenopausal patients.",

author = "Philip Furmanski and Saunders, {Dwight E.} and Brooks, {Samuel C.} and Rich, {Marvin A.}",

year = "1980",

month = dec,

day = "15",

doi = "10.1002/1097-0142(19801215)46:12+<2794::AID-CNCR2820461410>3.0.CO;2-N",

language = "English (US)",

volume = "46",

pages = "2794--2796",

journal = "Cancer",

issn = "0008-543X",

publisher = "John Wiley and Sons Inc.",

number = "12 S",

}

TY - JOUR

T1 - The prognostic value of estrogen receptor determinations in patients with primary breast cancer

T2 - An update

AU - Furmanski, Philip

AU - Saunders, Dwight E.

AU - Brooks, Samuel C.

AU - Rich, Marvin A.

PY - 1980/12/15

Y1 - 1980/12/15

N2 - Patients with estrogen receptor (E2R)‐positive breast cancers experience a longer disease‐free interval and longer survival following primary surgery than do patients with E2R‐negative tumors. The presence of E2R is correlated with patient age at diagnosis and tumor grade but not with the presence of metastatic foci in axillary lymph nodes. The difference in the rates of recurrence between E2R‐positive and negative tumors is greater in pre‐ and perimenopausal patients than in postmenopausal patients.

AB - Patients with estrogen receptor (E2R)‐positive breast cancers experience a longer disease‐free interval and longer survival following primary surgery than do patients with E2R‐negative tumors. The presence of E2R is correlated with patient age at diagnosis and tumor grade but not with the presence of metastatic foci in axillary lymph nodes. The difference in the rates of recurrence between E2R‐positive and negative tumors is greater in pre‐ and perimenopausal patients than in postmenopausal patients.

UR - http://www.scopus.com/inward/record.url?scp=0019201564&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019201564&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(19801215)46:12+<2794::AID-CNCR2820461410>3.0.CO;2-N

DO - 10.1002/1097-0142(19801215)46:12+<2794::AID-CNCR2820461410>3.0.CO;2-N

M3 - Article

C2 - 7448723

AN - SCOPUS:0019201564

SN - 0008-543X

VL - 46

SP - 2794

EP - 2796

JO - Cancer

JF - Cancer

IS - 12 S

ER -

The prognostic value of estrogen receptor determinations in patients with primary breast cancer: An update

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this